Thomas Blaschke

ORCID: 0000-0003-2674-799X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Computational Drug Discovery Methods
  • Machine Learning in Materials Science
  • Chemistry and Chemical Engineering
  • Genetics, Bioinformatics, and Biomedical Research
  • Protein Structure and Dynamics
  • History and advancements in chemistry
  • Microbial Natural Products and Biosynthesis
  • Receptor Mechanisms and Signaling
  • Process Optimization and Integration
  • Chemical Synthesis and Analysis
  • Modular Robots and Swarm Intelligence
  • Pharmacological Receptor Mechanisms and Effects
  • Neuropeptides and Animal Physiology
  • Evolutionary Algorithms and Applications
  • Viral Infectious Diseases and Gene Expression in Insects
  • Synthesis and biological activity
  • Various Chemistry Research Topics
  • Bioinformatics and Genomic Networks

Odyssey Therapeutics (United States)
2023

University of Bonn
2017-2021

AstraZeneca (Sweden)
2017-2020

Bonn Aachen International Center for Information Technology
2017

This work introduces a method to tune sequence-based generative model for molecular de novo design that through augmented episodic likelihood can learn generate structures with certain specified desirable properties. We demonstrate how this execute range of tasks such as generating analogues query structure and compounds predicted be active against biological target. As proof principle, the is first trained molecules do not contain sulphur. second example, drug Celecoxib, technique could...

10.1186/s13321-017-0235-x article EN cc-by Journal of Cheminformatics 2017-09-04

Abstract A major challenge in computational chemistry is the generation of novel molecular structures with desirable pharmacological and physiochemical properties. In this work, we investigate potential use autoencoder, a deep learning methodology, for de novo design. Various generative autoencoders were used to map molecule into continuous latent space vice versa their performance as structure generator was assessed. Our results show that preserves chemical similarity principle thus can be...

10.1002/minf.201700123 article EN cc-by Molecular Informatics 2017-12-13

In the past few years, we have witnessed a renaissance of field molecular de novo drug design. The advancements in deep learning and artificial intelligence (AI) triggered an avalanche ideas on how to translate such techniques variety domains including A range architectures been devised find optimal way generating chemical compounds by using either graph- or string (SMILES)-based representations. With this application note, aim offer community production-ready tool for design, called...

10.1021/acs.jcim.0c00915 article EN Journal of Chemical Information and Modeling 2020-10-29

Recent applications of recurrent neural networks (RNN) enable training models that sample the chemical space. In this study we train RNN with molecular string representations (SMILES) a subset enumerated database GDB-13 (975 million molecules). We show model trained 1 structures (0.1% database) reproduces 68.9% entire after training, when sampling 2 billion molecules. also developed method to assess quality process using negative log-likelihood plots. Furthermore, use mathematical based on...

10.1186/s13321-019-0341-z article EN cc-by Journal of Cheminformatics 2019-03-12

In de novo molecular design, recurrent neural networks (RNN) have been shown to be effective methods for sampling and generating novel chemical structures. Using a technique called reinforcement learning (RL), an RNN can tuned target particular section of space with optimized desirable properties using scoring function. However, ligands generated by current RL so far tend relatively low diversity, sometimes even result in duplicate structures when optimizing towards desired properties. Here,...

10.1186/s13321-020-00473-0 article EN cc-by Journal of Cheminformatics 2020-11-10

A major challenge in computational chemistry is the generation of novel molecular structures with desirable pharmacological and physiochemical properties. In this work, we investigate potential use autoencoder, a deep learning methodology, for de novo design. Various generative autoencoders were used to map molecule into continuous latent space vice versa their performance as structure generator was assessed. Our results show that preserves chemical similarity principle thus can be analogue...

10.48550/arxiv.1711.07839 preprint EN other-oa arXiv (Cornell University) 2017-01-01

With this application note we aim to offer the community a production-ready tool for de novo design. It can be effectively applied on drug discovery projects that are striving resolve either exploration or exploitation problems while navigating chemical space. By releasing code aiming facilitate research using generative methods and promote collaborative efforts in area so it used as an interaction point future scientific collaborations.

10.26434/chemrxiv.12058026 preprint EN cc-by-nc-nd 2020-04-03

Assay interference compounds give rise to false-positives and cause substantial problems in medicinal chemistry. Nearly 500 compound classes have been designated as pan-assay (PAINS), which typically occur substructures other molecules. The structural environment of PAINS is likely play an important role for their potential reactivity. Given the large number highly variable contexts, it difficult study context dependence on basis expert knowledge. Hence, we applied machine learning predict...

10.1021/acs.jmedchem.8b01404 article EN Journal of Medicinal Chemistry 2018-11-13

The ability of compounds to interact with multiple targets is also referred as promiscuity. Multitarget activity pharmaceutically relevant provides the foundation polypharmacology. Promiscuity cliffs (PCs) were introduced a data structure identify and organize similar large differences in Many PCs obtained on basis biological screening or compound from medicinal chemistry. In this work, used source different classes promiscuous nonpromiscuous close structural relationships. Various machine...

10.1021/acsomega.9b00492 article EN publisher-specific-oa ACS Omega 2019-04-16

Abstract Exploring the origin of multi-target activity small molecules and designing new compounds are highly topical issues in pharmaceutical research. We have investigated ability a generative neural network to create compounds. Data sets experimentally confirmed multi-target, single-target, consistently inactive were extracted from public screening data considering positive negative assay results. These used fine-tune REINVENT model via transfer learning systematically recognize...

10.1007/s10822-021-00392-8 article EN cc-by Journal of Computer-Aided Molecular Design 2021-05-28

Recent applications of Recurrent Neural Networks enable training models that sample the chemical space. In this study we train RNN with molecular string representations (SMILES) a subset enumerated database GDB-13 (975 million molecules). We show model trained 1 structures (0.1 % database) reproduces 68.9 entire after training, when sampling 2 billion molecules. also developed method to assess quality process using log-likelihood plots. Furthermore, use mathematical based on “coupon...

10.26434/chemrxiv.7172849 preprint EN cc-by 2018-10-09

With this application note we aim to offer the community a production-ready tool for de novo design. It can be effectively applied on drug discovery projects that are striving resolve either exploration or exploitation problems while navigating chemical space. By releasing code aiming facilitate research using generative methods and promote collaborative efforts in area so it used as an interaction point future scientific collaborations.

10.26434/chemrxiv.12058026.v1 preprint EN cc-by-nc-nd 2020-04-03

With this application note we aim to offer the community a production-ready tool for de novo design. It can be effectively applied on drug discovery projects that are striving resolve either exploration or exploitation problems while navigating chemical space. By releasing code aiming facilitate research using generative methods and promote collaborative efforts in area so it used as an interaction point future scientific collaborations.

10.26434/chemrxiv.12058026.v2 preprint EN cc-by-nc-nd 2020-04-08

The lipid-activated G protein-coupled receptor (GPCR) GPR55 has been proposed as a drug target for the treatment of chronic diseases including inflammation, neurodegeneration, neuropathic pain, metabolic diseases, and cancer. A series chromen-4-one-2-carboxylic acid derivatives was synthesized with aim to obtain potent selective ligands by (i) attachment variety substituted 8-benzamido residues, (ii) substitution in position 6 halogen atoms, (iii) thioation 4-oxo function. compounds were...

10.1021/acsomega.8b03695 article EN publisher-specific-oa ACS Omega 2019-02-26

This work introduces a method to tune sequence-based generative model for molecular de novo design that through augmented episodic likelihood can learn generate structures with certain specified desirable properties. We demonstrate how this execute range of tasks such as generating analogues query structure and compounds predicted be active against biological target. As proof principle, the is first trained molecules do not contain sulphur. second example, drug Celecoxib, technique could...

10.48550/arxiv.1704.07555 preprint EN other-oa arXiv (Cornell University) 2017-01-01

Compounds with the ability to interact multiple targets, also called promiscuous compounds, provide basis for polypharmacological drug discovery. In recent years, a plethora of structural analogs different promiscuity has been identified. Nevertheless, molecular origins remain be elucidated. this study, we systematically extracted varying using matched pair (MMP) formalism from public biological screening and medicinal chemistry data. Care was taken eliminate all compounds potential...

10.1002/minf.202000196 article EN cc-by-nc-nd Molecular Informatics 2020-09-03

Abstract In de novo molecular design, recurrent neural networks (RNN) have been shown to be effective methods for sampling and generating novel chemical structures. Using a technique called reinforcement learning (RL), an RNN can tuned target particular section of space with optimized desirable properties using scoring function. However, ligands generated by current RL so far tend relatively low diversity, sometimes even result in duplicate structures when optimizing towards desired...

10.21203/rs.3.rs-52871/v2 preprint EN cc-by Research Square (Research Square) 2020-11-04

Aim: Generating a data and software infrastructure for evaluating multi-target compound (MT-CPD) design via deep generative modeling. Methodology: The REINVENT 2.0 approach modeling was extended MT-CPD large benchmark set curated. Exemplary results & data: Proof-of-concept established. Custom code the comprising 2809 MT-CPDs, 61,928 single-target 295,395 inactive compounds from biological screens are made freely available. Limitations next steps: learning is still at its conceptual stages....

10.2144/fsoa-2021-0033 article EN cc-by Future Science OA 2021-04-30

Abstract In de novo molecular design, recurrent neural networks (RNN) have been shown to be effective methods for sampling and generating novel chemical structures. Using a technique called reinforcement learning (RL), an RNN can tuned target particular section of space with optimized desirable properties using scoring function. However, ligands generated by current RL so far tend relatively low diversity, sometimes even result in duplicate structures when optimizing towards properties....

10.21203/rs.3.rs-52871/v1 preprint EN cc-by Research Square (Research Square) 2020-08-06

Recent applications of Recurrent Neural Networks enable training models that sample the chemical space. In this study we train RNN with molecular string representations (SMILES) a subset enumerated database GDB-13 (975 million molecules). We show model trained 1 structures (0.1 % database) reproduces 68.9 entire after training, when sampling 2 billion molecules. also developed method to assess quality process using log-likelihood plots. Furthermore, use mathematical based on “coupon...

10.26434/chemrxiv.7172849.v2 preprint EN cc-by 2018-10-19

In de novo molecular design, recurrent neural networks (RNN) have been shown to be effective methods for sampling and generating novel chemical structures. Using a technique called reinforcement learning (RL), an RNN can tuned target particular section of space with optimized desirable properties using scoring function. However, ligands generated by current RL so far tend relatively low diversity, sometimes even result in duplicate structures when optimizing towards properties. Here, we...

10.26434/chemrxiv.12693152.v1 preprint EN cc-by-nc-nd 2020-07-23

Deep learning has gained significant attention in remote sensing, especially pixel- or patch-level applications. Despite initial attempts to integrate deep into object-based image analysis (OBIA), its full potential remains largely unexplored. In this article, as OBIA usage becomes more widespread, we conducted a comprehensive review and expansion of task subdomains, with without the integration learning. Furthermore, have identified summarized five prevailing strategies address challenge...

10.48550/arxiv.2408.01607 preprint EN arXiv (Cornell University) 2024-08-02

Recent applications of Recurrent Neural Networks enable training models that sample the chemical space. In this study we train RNN with molecular string representations (SMILES) a subset enumerated database GDB-13 (975 million molecules). We show model trained 1 structures (0.1 % database) reproduces 68.9 entire after training, when sampling 2 billion molecules. also developed method to assess quality process using log-likelihood plots. Furthermore, use mathematical based on “coupon...

10.26434/chemrxiv.7172849.v1 preprint EN cc-by 2018-10-09
Coming Soon ...